Richter CEO: profitability improved in all business lines, high single-digit revenue growth possible
Cost levels and profitability have improved in all business lines, and this year pharmaceutical production revenues may achieve high single-digit growth adjusted for exchange rates – said Gábor Orbán, CEO of Gedeon Richter Plc., in his online briefing following the flash report on Friday.
He pointed out that they do not provide stable performance on a quarterly basis, but rather think “on an annual or multi-year horizon“. The trade war left its mark on 2025, this year will no longer be about that, he said in response to MTI’s question.
He added: gynecology is one of their largest and fastest-growing business lines. Thanks to the innovative portfolio, they achieved the revenue growth in pharmaceutical production that was in line with their goals, which increased by 8.3 percent to nearly 2.31 billion euros last year, adjusted for exchange rates.
Related news
The future doesn’t wait: Bosch and Richter are looking for a new generation of innovators
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >The GVH is investigating the market for over-the-counter medicines.
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >AstraZeneca increases quarterly profit
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Related news
Festival buzz at the 60th anniversary EuroShop trade fair
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Historic price reduction at ALDI
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >A stable compass in the Hungarian FMCG sector for 20 years
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >


